Eli Lilly And Company (LLY) - News Archive

Organovo Completes Strategic Sale of FXR Program to Eli Lilly Amid Impressive Financial Growth In a notable strategic transaction in the biotechnology sector, San Diego-based Organovo Holdings, Inc. (Nasdaq: ONVO) has f...

Breaking News: Organovo Holdings Completes Strategic Sale of FXR Program to Eli LillySAN DIEGO, March 25, 2025 — Organovo Holdings, Inc. (Nasdaq: ONVO), a pioneering biotechnology firm dedicated to innovative treatments...

GordonMD Global Investments, the prominent investment firm, has announced that its portfolio company, Radionetics Oncology, has entered into a strategic agreement with Eli Lilly and Company, a global pharmaceutical gian...

In the competitive world of pharmaceuticals, finding a company that showcases impressive growth potential while maintaining financial stability is a key for investors. Eli Lilly and Company (NYSE:LLY) has recently emerg...

In recent years, Eli Lilly and Co. (NYSE: LLY) has been at the forefront of innovation, with several noteworthy developments and collaborations in the pharmaceutical industry. However, while the company s stocks have sh...

Eli Lilly and Company: A Look at Recent News and PerformanceSince the start of the year, the performance of Eli Lilly shares has outpaced that of the CSIMarkets index, demonstrating the company s strength in the market....